However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novavax, Inc. (“Novavax” or ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Vyalev’s clearance is the second victory for AbbVie in Parkinson’s this year, following an April readout for a drug acquired through its Cerevel buyout.

The report involved motor neuropathy in a participant of the phase 2 trial conducted outside the U.S., according to an Oct. 16 news release from the company. The participant received the vaccine in ...

Analyst Eric Joseph of J.P. Morgan maintained a Sell rating on Novavax (NVAX – Research Report), retaining the price target of $9.00.

The regulator placed a clinical hold on its Covid-19-influenza combination vaccine after one person reported nerve damage.

Standing desks may increase the risk of swollen veins and blood clots, a study in the International Journal of Epidemiology ...

The number of people with a medical bill on a credit report is down. But researchers found the decline was smaller in places ...

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its ...

Novavax said federal regulators put a clinical hold on its application for a combination Covid-19 and influenza vaccine and ...

Recent health news highlights various topics including Abbott's profit rise due to medical device sales, Trump's IVF comments ...